Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

BACKGROUND: Fluticasone furoate (FF)/vilanterol (VI) is a once daily (OD) inhaled corticosteroid/long-acting β(2)-agonist combination asthma therapy approved in Japan and the EU. FF/VI efficacy and safety data from asthma studies including patients in East Asia were evaluated to assess ethnic sensit...

Descripción completa

Detalles Bibliográficos
Autores principales: Gross, Annette S., Goldfrad, Caroline, Hozawa, Soichiro, James, Mark H., Clifton, Christine S., Sugiyama, Yutaro, Jacques, Loretta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690330/
https://www.ncbi.nlm.nih.gov/pubmed/26704701
http://dx.doi.org/10.1186/s12890-015-0159-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690330/
https://www.ncbi.nlm.nih.gov/pubmed/26704701
http://dx.doi.org/10.1186/s12890-015-0159-z

Ejemplares similares